African Americans with hypertensive kidney disease benefit from an ACE inhibitor
Initial findings of the AASK
Mahboob Rahman, MD, MS
Assistant Professor of Medicine, Divisions of Hypertension and Nephrology, Case Western Reserve University, University Hospitals of Cleveland; Louis Stokes Cleveland VA Medical Center; investigator, African American Study of Kidney Disease and Hypertension
Address: Mahboob Rahman, MD, MS, Divisions of Hypertension and Nephrology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland OH 44106; e-mail: firstname.lastname@example.org
The author has indicated that he has received honoraria for speaking engagements from the Solvay, Abbott, and Pfizer companies.
ABSTRACTExperts have long thought that African Americans were less responsive to ACE inhibitors than other racial or ethnic groups. The African American Study of Kidney Disease and Hypertension (AASK) provides the first evidence of a beneficial effect of ACE inhibition on renal function in African American patients, in addition to excellent blood pressure control.